Interleukin-2 potentiates foot-and-mouth disease vaccinal immune responses in mice

Vaccine

Volumn 23, Issue 23, 2005, Pages 3005-3009

  Yadav, Shikha ^a   Sharma, R ^a   Chhabra, Rajesh ^a  

^a CCS HARYANA AGRICULTURAL UNIVERSITY   (India)

Author keywords

Foot and mouth disease; IL 2; Immune response; Mice; Oil adjuvant vaccine

Indexed keywords

ANTIBODY; FOOT AND MOUTH DISEASE VACCINE; IMMUNOMODULATING AGENT; MITOGENIC AGENT; PHOSPHATE BUFFERED SALINE; RAKSHA OVAC; RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; EXPERIMENTAL MODEL; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; FOOT AND MOUTH DISEASE VIRUS TYPE A22; FOOT AND MOUTH DISEASE VIRUS TYPE ASIA 1; FOOT AND MOUTH DISEASE VIRUS TYPE O; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; INOCULATION; LYMPHOCYTE PROLIFERATION; MALE; MOLECULE; MONONUCLEAR CELL; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SPLEEN CELL; VACCINATION;

EID: 16244411646     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.12.005     Document Type: Article

References (25)

1. E.J. Usherwood, and A.A. Nash Lymphocyte recognition of picornaviruses J Gen Virol 76 1995 499 508
2. M.V. Borca, F.M. Fernandez, A.M. Sadir, M. Broun, and A.A. Schudel Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus independent primary and secondary reaction Immunology 59 1986 261 267
3. D.O. Morgan, D. Moore, and P. McKercher Vaccination against foot-and-mouth disease A. Mizsachi I. Hertman M.A. Kingberg A. Kohn New developments with human and veterinary vaccines 1980 Alan A. Liss New York p. 169-78
4. S.J. Barteling, and J. Vreeswijk Developments in foot-and-mouth disease vaccines Vaccine 9 1991 75 88
5. A.W. Heath, and J.H.L. Playfair Cytokines as immunological adjuvants Vaccine 10 1992 427 434
6. G. Anderson, O. Urbano, P. Fedorka-Cray, A. Newell, J. Nunberg, and M. Doyle Interleukin-2 and protective immunity in Haemophilus pleuro pneumoniae. Preliminary studies Vaccines vol. 87 1987 Cold Spring Harbor Press p. 22-5
7. A. Weinberg, and T.C. Merigan Recombinant interleukin-2 as an adjuvant for vaccine induced protection; immunization of Guinea pigs with Herpes Simplex virus subunit vaccines J Immunol 140 1988 294 299
8. J.H. Nunberg, M.V. Doyle, S.M. York, and C.J. York Interleukin-2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine Proc Natl Acad Sci USA 86 1989 4240 4243
9. H.P.A. Hughes, M. Campos, D.L. Godson, Van Drunen Littel-van denHurk, L. McDougall, and N. Rapin Immuno potentiation of bovine herpes virus subunit vaccination by interleukin-2 Immunology 74 1991 461 466
10. K.C. McCullough, L. Pullen, and D. Parkinson The immune response against foot-and-mouth disease virus: influence of the T lymphocyte growth factors IL-1 and IL-2 on the murine humoral immune response in vivo Immunol Lett 31 1991 41 46
11. R.J. Ho, R.L. Burke, and T.C. Merigan Liposome formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein D for the treatment of recurrent genital HSV-2 in guinea pigs Vaccine 10 1992 209 213
12. T.T. Chen, M.H. Tao, and R. Levy Idiotype cytokine fusion proteins as cancer vaccines: relative efficacy of IL-2, IL-4 and granulocyte-macrophage colony stimulating factor J Immunol 805 1994 4775 4785
13. D.C. Derosa, and L.M. Sordillo Efficacy of a bovine Staphylococcus aureus vaccine using interleukin-2 as an adjuvant J Vet Med Ser B 44 1997 599 607
14. P. Ralph, G. Jeong, and K. Welte Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL-2 J Immunol 133 1984 2442 2445
15. H.G. Bahnemann Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production Arch Virol 47 1975 47 56
16. K.C. McCullough, J.R. Crowther, and R.N. Butcher Alteration in antibody reactivity with foot-and-mouth disease virus 146 S antigen before and after binding to a solid phase or complexing with specific antibody J Immunol Methods 82 1985 91
17. V.E.C.J. Schijns, Claassen, J.Th.M. Ivo, A.A. Vermeulen, M.C. Horzinek, and A.D.M.E. Osterhaus Modulation of antiviral immune responses by exogenous cytokines: effects of tumor neuroses factor-α, interleukin-1α, interleukin-2 and interferon-γ on the immunogenicity of an inactivated rabies vaccine J Gen Virol 75 1994 55 63
18. P.G. Reddy, F. Blecha, H.C. Minocha, G.A. Anderson, J.L. Morrill, and P.J. Fedorka-Cray Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpes virus infection Vet Immunol Immunopathol 23 1989 61 74
19. P.H. Anderson, A.C. Ochoa, and J. Estrada IL-2 in liposomes as an immunological adjuvant FASEB J 4 1989 A318
20. J.N. Mbawuike, P.R. Wyde, and P.M. Anderson Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes Vaccine 8 1990 347 352
21. A. Gearing, R. Thorpe, C. Bird, and M. Spitz Human B cell proliferation is stimulated by interleukin-2 Immunol Lett 9 1985 105 108
22. N. Tsudo, T. Uchiyama, and H. Uchino Expression of Tac antigen on activated normal human B cells J Exp Med 160 1984 612 617
23. T. Collen, L. Pullen, and T.R. Doel T cell dependent induction of antibody against foot-and-mouth disease virus in a mouse model J Gen Virol 70 1989 395 403
24. H.P.A. Hughes, M. Campos, Van Drunen Littel-van den Hurk, T. Zamb, L.M. Sordillo, and D. Godson Multiple administration with interleukin-2 potentiates antigen specific responses to subunit vaccination with bovine herpes-1, glycoprotein IV Vaccine 10 1992 226 230
25. H. Kawamura, S. Rosenberg, and J.A. Berzofsky Immunization with antigen and interleukin-2 in vitro overcomes Ir gene low responsiveness J Exp Med 162 1985 381 386